Cantor Fitzgerald, L. P.
- SEC CIK
- 0001024896
- Latest filing
- Aug 19, 2026
PSTX holding history
Poseida Therapeutics, Inc. in every 13F filed by Cantor Fitzgerald, L. P., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
PSTX overviewAll 13F holders of PSTXFull Q2 2026 holdings
- Shares (Q3 2024)
- 0
- Sold out in Q3 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 7
- Since Q4 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2024 | 0 | $0 | 0.0% | −50,205−100.0% | Sold out | Holders |
| Q2 2024 | 50,205 | $146.6K | <0.1% | −25,000−33.2% | Reduced | Holders |
| Q1 2024 | 75,205 | $239.9K | 0.1% | +25,000+49.8% | Added | Holders |
| Q4 2023 | 50,205 | $168.7K | <0.1% | +50,205 | New | Holders |
| Q4 2022 | 0 | $0 | 0.0% | −45,205−100.0% | Sold out | Holders |
| Q3 2022 | 45,205 | $160.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2022 | 45,205 | $117.0K | <0.1% | +15,000+49.7% | Added | Holders |
| Q1 2022 | 30,205 | $135.0K | <0.1% | +5,000+19.8% | Added | Holders |
| Q4 2021 | 25,205 | $172.0K | <0.1% | – | No prior filing | Holders |